Active Ingredient(s): Aminolevulinic Acid Hydrochloride
FDA Approved: * June 6, 2017
Pharm Company: * NX DEVELOPMENT
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gleolan Overview

δ-Aminolevulinic acid (also dALA, δ-ALA, 5ALA or 5-aminolevulinic acid), an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme[1] in mammals, as well as chlorophyll[2] in plants. 5ALA is used in photodynamic detection and surgery of cancer.[3][4][5][6] Contents 1 Medical uses 1.1 Cancer diagnosis 1.2 Cancer ...

Read more Gleolan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Gleolan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Aminolevulinic Acid Hydrochloride
  • For Solution: 1.5gm/vial
  • Gel: 10%, 78mg
  • Solution: 1500mg, 20%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Gleolan: (1 result)

Sorted by National Drug Code
  • 71469-231 Gleolan 1500 mg Oral Powder, for Solution by Nx Development Corp

Other drugs which contain Aminolevulinic Acid Hydrochloride or a similar ingredient: (3 results)